BOSTON SCIENTIFIC CORPORATION Gain (Loss) on Extinguishment of Debt
BOSTON SCIENTIFIC CORPORATION (BSX) reported Gain (Loss) on Extinguishment of Debt of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-18.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2025-02-18
- BOSTON SCIENTIFIC CORPORATION gain (loss) on extinguishment of debt for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION gain (loss) on extinguishment of debt for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION gain (loss) on extinguishment of debt for the quarter ending 2023-06-30 was $0.00.
- BOSTON SCIENTIFIC CORPORATION gain (loss) on extinguishment of debt for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION gain (loss) on extinguishment of debt for fiscal 2024 was $0.00.
- BOSTON SCIENTIFIC CORPORATION gain (loss) on extinguishment of debt for fiscal 2023 was $0.00.
- BOSTON SCIENTIFIC CORPORATION gain (loss) on extinguishment of debt for fiscal 2022 was -$194.00M.
- BOSTON SCIENTIFIC CORPORATION gain (loss) on extinguishment of debt for fiscal 2021 was $0.00.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 3 month as first filed | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-18 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $0.00 derived: sum of 2 quarters · filed 2025-02-18 | $0.00 derived: sum of 3 quarters · filed 2025-02-18 | $0.00 10-K · filed 2025-02-18 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $0.00 derived: sum of 2 quarters · filed 2023-11-01 | $0.00 10-Q · filed 2023-11-01 | $194.00M derived: sum of 4 quarters · filed 2023-11-01 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $0.00 10-Q · filed 2023-08-03 | $194.00M derived: sum of 3 quarters · filed 2023-08-03 | $388.00M derived: sum of 4 quarters · filed 2023-08-03 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-04 | $194.00M derived: sum of 2 quarters · filed 2023-05-04 | $388.00M derived: sum of 3 quarters · filed 2023-05-04 | $0.00 derived: sum of 4 quarters · filed 2023-08-03 | |
| 2022-12-31 | $194.00M 10-K · filed 2023-02-23 | $388.00M derived: sum of 2 quarters · filed 2023-02-23 | $0.00 derived: sum of 3 quarters · filed 2023-08-03 | -$194.00M 10-K · filed 2025-02-18 | |
| 2022-09-30 | $194.00M 10-Q · filed 2022-11-03 | -$194.00M derived: sum of 2 quarters · filed 2023-08-03 | -$194.00M 10-Q · filed 2023-11-01 | $0.00 derived: sum of 4 quarters · filed 2025-02-18 | |
| 2022-06-30 | -$388.00M derived: 10-Q 6 month − 10-K 3 month · filed 2023-08-03 | -$194.00M 10-Q · filed 2023-08-03 | -$194.00M derived: sum of 3 quarters · filed 2025-02-18 | -$194.00M derived: sum of 4 quarters · filed 2025-02-18 | |
| 2022-03-31 | $194.00M 10-K · filed 2025-02-18 | -$194.00M 10-Q · filed 2022-05-05 | $194.00M derived: sum of 2 quarters · filed 2025-02-18 | $194.00M derived: sum of 3 quarters · filed 2025-02-18 | $194.00M derived: sum of 4 quarters · filed 2025-02-18 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $0.00 derived: sum of 2 quarters · filed 2024-02-20 | $0.00 derived: sum of 3 quarters · filed 2024-02-20 | $0.00 10-K · filed 2024-02-20 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $0.00 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $0.00 10-Q · filed 2022-08-04 | |||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-05 | ||||
| 2019-12-31 | $86.00M 10-K · filed 2022-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |